Osiris Therapeutics competitors and similar companiesClear all

Osiris Therapeutics's competitors and similar companies include ACell, GeneDx, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical and Poseida Therapeutics.

	Osiris Therapeutics Osiris Therapeutics is a company that researches, develops, manufactures, markets, and distributes regenerative medicine products.	ACell ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair.	GeneDx GeneDx is a company operating in the genetics and genomics industry.	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.	Poseida Therapeutics Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.
Founding Date	Founding Date 1992	Founding Date 2002	Founding Date 2000	Founding Date 1996	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech genetics	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations Columbia, US HQ	Locations Columbia, US HQ Lafayette, US	Locations Gaithersburg, US HQ	Locations CN HQ	Locations San Diego, US HQ
Employees	Employees 185	Employees 400	Employees 6122% increase	Employees 817	Employees 2801% increase
Alexa Website Rank	Alexa Website Rank 141951	Alexa Website Rank 323161	Alexa Website Rank 421995	Alexa Website Rank 110606	Alexa Website Rank 328746
Employee Rating	Employee Rating 2.7	Employee Rating 3.7	Employee Rating 3.3	Employee Rating N/A	Employee Rating 4.6
Financial
Revenue (est.)	Revenue (est.) $142.8m (FY, 2018)	Revenue (est.) $100.8m (FY, 2019)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $38.1m (FY, 2018)	Cost of goods $19.1m (FY, 2019)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $104.7m (FY, 2018)	Gross profit $81.7m (FY, 2019)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income $36.9m (FY, 2018)	Net income $1.4m (FY, 2019)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 65m	Total funding raised $ 8.7m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 336.5m